• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, November 16, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Tart cherry shown to decrease joint pain, sore muscles in some breast cancer patients

Bioengineer by Bioengineer
June 10, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

HUNTINGTON, W.Va. – Tart cherry reduces the musculoskeletal effects of aromatase inhibitors in patients with non-metastatic breast cancer, according to new findings from a clinical trial by researchers at Marshall University Joan C. Edwards School of Medicine and Edwards Comprehensive Cancer Center.

Aromatase inhibitors (AIs) are a standard treatment for hormone receptor-positive breast cancer in postmenopausal women. These agents can help prevent recurrence of the disease by inhibiting the action of aromatase, an enzyme responsible for conversion of androgens to estrogens. About half of patients who take AIs also suffer from joint and muscle pain known as aromatase inhibitor induced arthralgia, which, at times, can be debilitating and cause patients to not complete their treatments.

This randomized, double-blind trial compared the consumption of 1 ounce of tart cherry concentrate in 8 ounces of water daily for six weeks with a placebo group in women with stage 1, 2 or 3 non-metastatic breast cancer. A total of 60 patients were enrolled throughout the course of the clinical trial, conducted May 2016 to August 2018.

Patients documented their pain intensity at the start of the trial, weekly and at study completion. Patients who completed the trial recorded a 34.7% mean decrease in pain compared to 1.4% in the placebo group.

“The flavonoids and anthocyanins in tart cherry have anti-inflammatory properties and may be playing a role in reducing the side effects of joint pain and muscles aches, although etiology of aromatase-induced arthralgias remain unclear at this time,” said principal investigator Maria Tria Tirona, M.D., professor of hematology-oncology at the Marshall University Joan C. Edwards School of Medicine and director of medical oncology at Edwards Comprehensive Cancer Center. “There was a statistically significant difference in the pain levels experienced by patients in the group that received the tart cherry concentrate compared to the placebo group.”

###

The team presented its findings on June 2, 2019, at the American Society of Clinical Oncology annual meeting in Chicago. First author, Mina Shenouda, M.D., a hematology-oncology fellow at the Joan C. Edwards School of Medicine, received a Conquer Cancer Merit Award from the ASCO Foundation for this study.

The study was funded by the Cherry Marketing Institute (CMI). CMI did not influence the development of the study, analyses of the data or decision to present the results. Study 844511 has been approved by the Marshall University Institutional Review Board #1.

Media Contact
Sheanna Spence
smith566@marshall.edu
https://jcesom.marshall.edu/news/musom-news/tart-cherry-shown-to-decrease-joint-pain-sore-muscles-in-breast-cancer-patients-receiving-aromatase-inhibitors/

Tags: Breast CancercancerMedicine/HealthNutrition/Nutrients
Share13Tweet8Share2ShareShareShare2

Related Posts

Phosphorylation Signature Distinguishes Hallucinogenic and Non-Hallucinogenic Psychedelics in Neural Cells

Phosphorylation Signature Distinguishes Hallucinogenic and Non-Hallucinogenic Psychedelics in Neural Cells

November 16, 2026
Ultrasound-Guided Shockwave Lithotripsy Reduces Pediatric Complications Without Sacrificing Stone Clearance

Ultrasound-Guided Shockwave Lithotripsy Reduces Pediatric Complications Without Sacrificing Stone Clearance

November 16, 2026

Computational Modeling Implicates NMDA Receptor Hypofunction in 22q11.2 Deletion Syndrome

November 16, 2026

Prenatal Dexamethasone Exposure Impairs Hippocampal Neurogenesis and Promotes Depression in Mice

November 16, 2026
Please login to join discussion

POPULAR NEWS

  • Repetitive Behaviors Link Autistic Traits Between Children and Parents in Family Study

    Repetitive Behaviors Link Autistic Traits Between Children and Parents in Family Study

    29 shares
    Share 12 Tweet 7
  • Urinary Calprotectin Outperforms Novel Biomarkers in Pediatric Acute Kidney Injury Differentiation

    29 shares
    Share 12 Tweet 7
  • Twelve Percent of Children with Neuroblastoma Experience Initial Musculoskeletal Misdiagnoses

    29 shares
    Share 12 Tweet 7
  • Tunable Plasma Photonic Crystals Enable Dynamic Control Over Topology and Electromagnetism

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Phosphorylation Signature Distinguishes Hallucinogenic and Non-Hallucinogenic Psychedelics in Neural Cells

Ultrasound-Guided Shockwave Lithotripsy Reduces Pediatric Complications Without Sacrificing Stone Clearance

Systematic Review Links Diet and Processed Foods to Systemic Microplastic Exposure

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.